These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4478622)

  • 1. [Proceedings: Effects of reserpine, 6-OHDA, L-DOPA and 5-HTP on the development of sex glands in male rats].
    Matsuyama S
    Nihon Seirigaku Zasshi; 1974 Sep; 36(8-9):402. PubMed ID: 4478622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the dopamine content in the brain of Periplaneta americana L. after application of structural analogs of dopamine and reserpine].
    Prée J; Rutschke E
    Biomed Biochim Acta; 1983; 42(4):407-12. PubMed ID: 6226288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Alachkar A; Brotchie JM; Jones OT
    Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of L-DOPA, serotonin, reserpine and chlorpromazine on the daily rhythm of fluorescent intensity in leucocytes and blood platelets.
    Mato M; Ookawara S; Uchiyama Y
    Acta Histochem; 1976; 57(2):198-204. PubMed ID: 827904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
    Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late endocrine effects of L-dopa, 5-HTP, and 6-OH-dopa administered to neonatal rats.
    Bakke JL; Lawrence NL; Robinson SA; Bennett J; Bowers C
    Neuroendocrinology; 1978; 25(5):291-302. PubMed ID: 306584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine analgesia and its modification by drugs altering serotonin (5-HT) and dopamine levels in the brain.
    Shinde S; Gupta SK
    Indian J Physiol Pharmacol; 1977; 21(1):72-4. PubMed ID: 301504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of L-dopa and reserpine on the accumulation of 14C-methionine 14C-phenylalanine in the brain regions of rats].
    Antal J; Jászsági-Nagy E
    Radiobiol Radiother (Berl); 1978 Aug; 19(4):416-23. PubMed ID: 734080
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS; Fisher A; Starr MS
    Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal control of neurotransmitters biosynthesis during development.
    Giacobini E
    J Neurosci Res; 1975; 1(3-4):315-31. PubMed ID: 5613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increase of cerebral dopamine levels by alpha-chymotrypsin in rats pretreated with oxypertine and L-dopa].
    Van den Driessche J; Le Clec'h G; Quiniou P; Linée P; Lacroix P; Patay M; Delamaire J
    C R Seances Soc Biol Fil; 1974; 168(10-11-12):1393-400. PubMed ID: 4157065
    [No Abstract]   [Full Text] [Related]  

  • 13. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats.
    Lee J; Di Marzo V; Brotchie JM
    Neuropharmacology; 2006 Sep; 51(3):557-65. PubMed ID: 16806299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on catecholamine-containing specific endothelial granules in carp cerebral veins. A fluorescence histochemical and electron microscopy study.
    Iijima T; Wasano T
    Anat Rec; 1980 Nov; 198(3):415-20. PubMed ID: 7457935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of the reciprocal relationship of monoaminergic systems of the brain in the pharmacological compensation of 6-hydroxydopamine-induced behavior disorders in animals].
    Gromova EA; Semenova TP
    Biull Eksp Biol Med; 1989 Jan; 107(1):52-4. PubMed ID: 2521566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of L-5-hydroxytryptophan after destruction of ascending serotonergic pathways in the rat: the role of catecholaminergic neurons.
    Yunger LM; Harvey JA
    J Pharmacol Exp Ther; 1976 Feb; 196(2):307-15. PubMed ID: 1255478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study.
    Boulamery A; Simon N; Vidal J; Bruguerolle B
    Chronobiol Int; 2010 Jan; 27(2):251-64. PubMed ID: 20370468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interactions of cerebral serotonin and catecholamines].
    Watanabe Y
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):365-83. PubMed ID: 6195056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.